Related Experiment Video
Updated: Mar 2, 2026
07:21
Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
Published on: May 27, 2022
3.7K
Degradomics in Neurotrauma: Profiling Traumatic Brain Injury
Hadi Abou-El-Hassan1, Fares Sukhon2, Edwyn Jeremy Assaf3
1Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon. hia16@mail.aub.edu.
Methods in Molecular Biology (Clifton, N.J.)
|May 17, 2017
Summary
Degradomics studies protein breakdown products in diseases. In neural injury, specific protein fragments offer potential therapeutic targets for traumatic brain injury interventions.
Area of Science:
- Biochemistry
- Proteomics
- Neuroscience
Background:
- Degradomics is an emerging field focusing on disease-specific protein breakdown products.
- Proteases like MMPs play roles in disease pathogenesis by disrupting protein balance.
- Uncontrolled proteolysis contributes to cell death pathways.
Purpose of the Study:
- To review protease-substrate repertoires in neural injury, specifically traumatic brain injury.
- To highlight the significance of degradomics in understanding disease mechanisms.
Main Methods:
- Characterization of protease-substrate interactions in the context of brain injury.
- Identification of signature protein fragments (neoproteins) resulting from proteolytic activity.
Main Results:
- A diverse range of protease substrates crucial for neuronal integrity are identified in brain injury.
- These substrates include cytoskeletal proteins, transcription factors, and synaptic proteins.
- These fragmented proteins act as potential biomarkers.
Conclusions:
- Characterizing these neoproteins in traumatic brain injury provides insights into disease mechanisms.
- Understanding protease-substrate dynamics opens avenues for novel therapeutic interventions targeting the proteolytic cascade.
